Table 2 |
|||
|
Distribution of clusters of clinical outcomes |
|||
|
Cluster I: Severe RA (n = 26) |
Cluster II: Mild/moderate seropositive RA (n = 25) |
Cluster 3: Mild/moderate seronegative RA (n = 39) |
|
|
|
|||
|
Treated with biologics (ever) |
100% |
0 |
0 |
|
|
|||
|
RF positive |
88.5% |
100% |
0 |
|
|
|||
|
Documented erosions on radiographs (ever) |
84.6% |
56.4% |
52.0% |
|
|
|||
|
HAQ after 5 years |
|||
|
Mean (SD) |
1.17 (0.61) |
0.74 (0.61) |
0.88 (0.66) |
|
Median (IQR) |
1.00 (0.72-1.66) |
0.63 (0.38-0.88) |
0.88 (0.25-1.25) |
|
|
|||
|
HAQ, Health Assessment Questionnaire; IQR, interquartile range; RF, rheumatoid factor; SD, standard deviation. |
|||
|
Pikwer et al. Arthritis Research & Therapy 2012 14:R190 doi:10.1186/ar4021 |
|||